1 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 29487219 | A Phase II Trial of Selinexor, an Oral Selective Inhibitor of Nuclear Export Compound, in Abiraterone- and/or Enzalutamide-Refractory Metastatic Castration-Resistant Prostate Cancer. | 2018 Jun | 1 |